These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Should repeat thrombolysis be considered after early ischaemic stroke recurrence? Simpson MA; Dewey HM Int J Stroke; 2009 Aug; 4(4):237-8. PubMed ID: 19689747 [No Abstract] [Full Text] [Related]
25. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK. Walters MR; Muir KW; Harbison J; Lees KR; Ford GA Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848 [TBL] [Abstract][Full Text] [Related]
27. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator. Jain SV; Morton LD Pediatr Neurol; 2008 Feb; 38(2):126-9. PubMed ID: 18206794 [TBL] [Abstract][Full Text] [Related]
28. Stroke and thrombolysis in India. Pandian JD Neurol India; 2007; 55(2):173; author reply 173-4. PubMed ID: 17558128 [No Abstract] [Full Text] [Related]
29. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. Asahi M; Asahi K; Wang X; Lo EH J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108 [TBL] [Abstract][Full Text] [Related]
30. Prior anticoagulant therapy, subtherapeutic international normalized ratio and thrombolytic therapy in acute ischemic stroke. Miedema I; Gosselt A; de Keyser J; Koopman K; Kremer B; Luijckx GJ; Uyttenboogaart M Int J Stroke; 2011 Dec; 6(6):568-9. PubMed ID: 22111806 [No Abstract] [Full Text] [Related]
31. Hyperacute stroke therapy with tissue plasminogen activator. Alberts MJ Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041 [TBL] [Abstract][Full Text] [Related]
32. Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials. Lorenz MW; Lauer A; Foerch C Stroke; 2015 Nov; 46(11):3168-76. PubMed ID: 26443833 [TBL] [Abstract][Full Text] [Related]
33. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis. Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237 [TBL] [Abstract][Full Text] [Related]
34. Treatment of acute ischemic stroke, Part 1. Fullerton T J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931 [No Abstract] [Full Text] [Related]
35. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives]. Paris C; Derex L Rev Neurol (Paris); 2015 Dec; 171(12):866-75. PubMed ID: 26563662 [TBL] [Abstract][Full Text] [Related]
36. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Blacker DJ Med J Aust; 2004 Feb; 180(3):142-3; author reply 142-3. PubMed ID: 14748684 [No Abstract] [Full Text] [Related]